================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

                                  MAY 16, 2006
                Date of report (Date of earliest event reported)

                                IMAX CORPORATION
             (Exact Name of Registrant as Specified in Its Charter)


                                                    
           CANADA                      0-24216                  98-0140269
(State or Other Jurisdiction   (Commission File Number)      (I.R.S. Employer
      of Incorporation)                                   Identification Number)


           2525 SPEAKMAN DRIVE, MISSISSAUGA, ONTARIO, CANADA, L5K 1B1
             (Address of Principal Executive Offices) (Postal Code)

                                 (905) 403-6500
              (Registrant's Telephone Number, Including Area Code)

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written communication pursuant to Rule 425 under the Securities Act (17 CFR
     230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange
     Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange
     Act (17 CFR 240.13e-4(c))

================================================================================


                                     Page 1



ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

On May 16, 2006, IMAX Corporation (the "Company") entered into the Second
Amendment to the Loan Agreement with Wachovia Capital Finance Corporation
(Canada) (formerly, Congress Financial Corporation (Canada)) which increased the
line of credit available to the Company to US$40 million and extended the term
of this arrangement until October 31, 2009. A copy of the amendment is filed
herewith as Exhibit 10.27 and is incorporated herein by reference.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(D) EXHIBITS



EXHIBIT NO.   DESCRIPTION
-----------   -----------
           
10.27         Second Amendment to the Loan Agreement, dated May 16, 2006 between
              IMAX Corporation and Wachovia Capital Finance Corporation (Canada)
              (formerly, Congress Financial Corporation (Canada))



                                     Page 2



                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                      IMAX CORPORATION
                                      (Registrant)


Date: May 23, 2006                    By "Robert D. Lister"
                                         ---------------------------------------
                                      Name: Robert D. Lister
                                            Executive Vice President, Business &
                                            Legal Affairs and General Counsel


                                      By: "G. Mary Ruby"
                                          --------------------------------------
                                      Name: G. Mary Ruby
                                            Senior Vice President, Legal Affairs
                                            and Corporate Secretary


                                     Page 3



                                IMAX CORPORATION

                                  EXHIBIT 10.27


                                     Page 4